Sign in and upgrade to a paid plan to export futures history as CSV.

Unjha Formulations Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531762
₹32.50
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #171 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Unjha Formulations Ltd. (this stock) 15 31.0 18.3% 7.9% — 57 30 52

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹13 Cr
EV / EBITDA
14.7x
EV / Sales
0.85x
Market cap / Sales
0.95x
Earnings yield
3.23%

Quarterly Financials

↓ Negative
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 3 Cr, down 9.0% YoY.

↓ Negative
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 0 Cr, down 59.7% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 3 0 0 ₹0.3500
March 31, 2026 3 -0 -1 ₹-1.6600
Dec. 31, 2025 4 0 0 ₹0.5300
Sept. 30, 2025 4 1 1 ₹1.8300
June 30, 2025 4 0 0 ₹0.9000
Dec. 31, 2024 4 0 0 ₹0.5000
Sept. 30, 2024 4 -0 -0 ₹-0.2500
June 30, 2024 4 1 1 ₹1.5600
March 31, 2024 4 -0 -0 ₹-0.3900
Dec. 31, 2023 6 0 0 ₹0.8700
Sept. 30, 2023 5 -0 -0 ₹-0.2600
June 30, 2023 4 0 0 ₹0.4000
March 31, 2023 3 -0 -0 ₹-0.5000

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23
Total income (before exceptional items)3344444446543
Operating revenue3344444446543
Other income-000000000-00-00
Operating expenses3444344345543
Operating profit0-00100-0100-00-0
Operating profit margin5.9%-15.2%5.7%18.3%11.1%6.3%-2.9%18.2%1.4%7.4%-2.2%5.6%-4.1%
Depreciation0000000000000
Interest0000000000000
Exceptional items, gain / (loss)—————————————
Profit before tax0-00100-01-00-00-0
Tax—0——————0———0
Net profit0-10100-01-00-00-0
EPS0.35-1.660.531.830.900.50-0.251.56-0.390.87-0.260.40-0.50
Net profit (TTM)0121111100-000
EPS (TTM)1.051.603.762.982.711.421.791.780.620.51-0.570.920.62

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) 6.1% 9.1% 16†19†13†14†10†11†12†—12†
Operating revenue 5.8% 9.4% 16†18†13†14†10†11†11†11†12†
Other income — — 0†0†0†0†0†0†0†—0†
Operating expenses — — 15†18†13†14†10†10†11†11†12†
Operating profit 30.1% 46.6% 1†1†0†0†0†0†0†0†0†
Operating profit margin — — 6.0%†3.1%†3.2%†2.3%†1.4%†2.4%†2.7%†3.0%†3.2%†
Depreciation — — 0†0†0†0†0†0†0†0†0†
Interest — — 0†0†0†0†0†0†0†0†0†
Exceptional items, gain / (loss) — — 0†0†0†0†0†0†0†0†0†
Profit before tax 43.5% 56.1% 1†0†0†0†0†0†0†0†0†
Tax — — —————————
Net profit 36.7% 46.9% 1†0†0†0†0†0†0†0†0†
EPS 37.2% 47.4% 1.60†0.62†0.62†0.56†0.23†0.01†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin6.0%†3.1%†3.2%†2.3%†1.4%†2.4%†2.7%†3.0%†3.2%†
EBIT margin6.2%†2.7%†2.9%†3.1%†2.8%†4.0%†2.8%†2.4%†3.2%†
PBT margin6.1%†2.4%†2.5%†2.1%†1.0%†2.9%†2.6%†2.2%†2.4%†
Net margin4.5%†1.5%†2.1%†1.8%†1.0%†2.9%†2.6%†2.2%†2.4%†
Interest coverage123.31x†9.08x†6.59x†3.27x†1.60x†3.66x†15.40x†17.47x†3.92x†
Dividend payout—————————
Earnings retention—————————
Current ratio11.83x————————
Quick ratio10.06x————————
Debt to equity0.00x————————
Return on equity18.3%†————————
Return on assets12.8%†————————
Return on capital employed18.7%†————————
Asset turnover2.83x†————————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 1 -0 -0 0 1
March 31, 2025 -0 -0 -0 -0 -0

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 6 4 -1 0 0 4 0 2 1 1
March 31, 2025 5 3 -1 0 0 3 1 1 1 1

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.